Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at CNS Pharmaceuticals Inc fell by 9.51m. Cash Flow from Financing totalled 4.64m or -- of revenues. In addition the company used 14.14m for operations while cash used for investing totalled 3.90k.
Cash flow per share | -86.78 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -2.97 |
---|---|
Tangible book value per share | -2.97 |
More ▼
Balance sheet in USDView more
Current ratio | 0.3172 |
---|---|
Quick ratio | -- |
Total debt/total equity | -- |
---|---|
Total debt/total capital | -- |
More ▼